Design and processing of nanogels as delivery systems for peptides and proteins

Therapeutic Delivery

Volumn 5, Issue 6, 2014, Pages 691-708

  Arnfast, Lærke ^a   Madsen, Claus Greve ^a   Jorgensen, Lene ^a   Baldursdottir, Stefania ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; POLYMER; PROTEIN;

DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; GEL; HUMAN; NANOGEL; NANOTECHNOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW;

AMINO ACID SEQUENCE; DRUG DELIVERY SYSTEMS; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; PROTEINS;

EID: 84905509892     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.14.38     Document Type: Review

References (122)

1. Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA. Pancreatic extracts in the treatment of diabetes mellitus. Can. Med. Assoc. J. 7, 141-146 (1922).
2. Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov. 7(1), 21-39 (2008).
3. Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 4(4), 298-306 (2005).
4. Manning MC, Patel K, Borchardt RT. Stability of protein pharmaceuticals. Pharmaceut. Res. 6(11), 903-918 (1989).
5. Taverna DM, Goldstein RA. Why are proteins marginally stable? Proteins 46(1), 105-109 (2002).
6. Fields GB, Alonso DOV, Stigter D, Dill KA. Theory for the aggregation of proteins and copolymers. J. Phys. Chem. A 96(10), 3974-3981 (1992).
7. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int. J. Pharm. 289(1-2), 1-30 (2005).
8. Moghimi SM, Hamad I, Andresen TL, Jorgensen K, Szebeni J. Methylation of the phosphate oxygen moiety of phospholipidmethoxy( polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production. FASEB J. 20(14), 2591-2593 (2006).
9. US FDA. FDA approved PEG drugs. FDA Approved Drug Products. FDA, MD, USA (2013).
10. Webster R, Elliott V, Park BK, Walker D, Hankin M, Taupin P. PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals. In: PEGylated Protein Drugs: Basic Science and Clinical Applications. Veronese F (Eds). Birkhäuser, Basel, Switzerland, 127-146 (2009).
11. Van De Weert M, Jorgensen L, Horn Moeller E, Frokjaer S. Factors of importance for a successful delivery system for proteins. Expert Opin. Drug Deliv. 2(6), 1029-1037 (2005).
12. Pautler M, Brenner S. Nanomedicine: promises and challenges for the future of public health. Int. J. Nanomedicine 5, 803-809 (2010).
13. Min Y, Akbulut M, Kristiansen K, Golan Y, Israelachvili J. The role of interparticle and external forces in nanoparticle assembly. Nat. Mater. 7(7), 527-538 (2008).
14. Sasaki Y, Akiyoshi K. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chem. Rec. 10(6), 366-376 (2010).
15. Shimoda A, Yamamoto Y, Sawada S, Akiyoshi K. Biodegradable nanogel-integrated hydrogels for sustained protein delivery. Macromol. Res. 20(3), 266-270 (2012).
16. Hendrickson GR, Smith MH, South AB, Lyon LA. Design of multiresponsive hydrogel particles and assemblies. Adv. Funct. Mater. 20(11), 1697-1712 (2010).
17. Raemdonck K, Demeester J, De Smedt S. Advanced nanogel engineering for drug delivery. Soft Matter 5(4), 707-715 (2009).
18. Oh JK, Drumright R, Siegwart DJ, Matyjaszewski K. The development of microgels/nanogels for drug delivery applications. Prog. Polym. Sci. 33(4), 448-477 (2008).
19. Vinogradov S, Batrakova E, Kabanov A. Poly(ethylene glycol)- polyethyleneimine NanoGel (TM) particles: novel drug delivery systems for antisense oligonucleotides. Colloid Surf. B 16(1-4), 291-304 (1999).
20. Bencherif SA, Siegwart DJ, Srinivasan A et al. Nanostructured hybrid hydrogels prepared by a combination of atom transfer radical polymerization and free radical polymerization. Biomaterials 30(29), 5270-5278 (2009).
21. Akiyama E, Morimoto N, Kujawa P, Ozawa Y, Winnik FM, Akiyoshi K. Self-assembled nanogels of cholesteryl-modified polysaccharides: effect of the polysaccharide structure on their association characteristics in the dilute and semidilute regimes. Biomacromolecules 8(8), 2366-2373 (2007).
22. Kabanov AV, Vinogradov SV. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew. Chem. Int. Ed. 48(30), 5418-5429 (2009).
23. Moya-Ortega MD, Alvarez-Lorenzo C, Concheiro A, Loftsson T. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. Int. J. Pharm. 428(1-2), 152-163 (2012).
24. Nomura Y, Ikeda M, Yamaguchi N, Aoyama Y, Akiyoshi K. Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. FEBS Lett. 553(3), 271-276 (2003).
25. Nochi T, Yuki Y, Takahashi H et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat. Mater. 9(7), 572-578 (2010).
26. Ayame H, Morimoto N, Akiyoshi K. Self-assembled cationic nanogels for intracellular protein delivery. Bioconjug. Chem. 19(4), 882-890 (2008).
27. Vermonden T, Censi R, Hennink WE. Hydrogels for protein delivery. Chem. Rev. 112(5), 2853-2888 (2012).
28. Rowan SJ, Cantrill SJ, Cousins GRL, Sanders JKM, Stoddart JF. Dynamic covalent chemistry. Angew. Chem. Int. Ed. 41(6), 898-952 (2002).
29. Argentiere S, Blasi L, Morello G, Gigli G. A Novel pHresponsive nanogel for the controlled uptake and release of hydrophobic and cationic solutes. J. Phys. Chem. C 115(33), 16347-16353 (2011).
30. Kim Y, Thapa M, Hua DH, Chang KO. Biodegradable nanogels for oral delivery of interferon for norovirus infection. Antivir. Res. 89(2), 165-173 (2011).
31. Molinos M, Carvalho V, Silva DM, Gama FM. Development of a hybrid dextrin hydrogel encapsulating dextrin nanogel as protein delivery system. Biomacromolecules 13(2), 517-527 (2012).
32. Hoare T, Timko BP, Santamaria J et al. Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release. Nano Lett. 11(3), 1395-1400 (2011).
33. Salmaso S, Caliceti P. Self assembling nanocomposites for protein delivery: supramolecular interactions of soluble polymers with protein drugs. Int. J. Pharm. 440(1), 111-123 (2013).
34. Uskokovic V. Isnt self-assembly a misnomer? Multidisciplinary arguments in favor of co-assembly. Adv Colloid Interfac 141(1-2), 37-47 (2008).
35. Daoud-Mahammed S, Couvreur P, Bouchemal K et al. Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen. Biomacromolecules 10(3), 547-554 (2009).
36. Socoliuc V, Vekas L, Turcu R. Magnetically induced phase condensation in an aqueous dispersion of magnetic nanogels. Soft Matter 9(11), 3098-3105 (2013).
37. Yu SY, Yao P, Jiang M, Zhang GZ. Nanogels prepared by self-assembly of oppositely charged globular proteins. Biopolymers 83(2), 148-158 (2006).
38. Morimoto N, Hirano S, Takahashi H, Loethen S, Thompson DH, Akiyoshi K. Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle. Biomacromolecules 14(1), 56-63 (2013).
39. Bhuchar N, Sunasee R, Ishihara K, Thundat T, Narain R. Degradable thermoresponsive nanogels for protein encapsulation and controlled release. Bioconjug. Chem. 23(1), 75-83 (2012).
40. Kim J-Y, Choi WI, Kim YH et al. In-vivo tumor targeting of pluronic-based nano-carriers. J. Control. Release 147(1), 109-117 (2010).
41. Gudeman LF, Peppas NA. Preparation and characterization of Ph-sensitive, interpenetrating networks of poly(vinyl alcohol) and poly(acrylic acid). J. Appl. Polym. Sci. 55(6), 919-928 (1995).
42. Kim SJ, Lee KJ, Kim SI, Lee YM, Chung TD, Lee SH. Electrochemical behavior of an interpenetrating polymer network hydrogel composed of poly(propylene glycol) and poly(acrylic acid). J. Appl. Polym. Sci. 89(9), 2301-2305 (2003).
43. Kim SY, Lee YM. Drug release behavior of electrical responsive poly(vinyl alcohol)/poly(acrylic acid) IPN hydrogels under an electric stimulus. J. Appl. Polym. Sci. 74(7), 1752-1761 (1999).
44. Laguecir A, Ulrich S, Labille J, Fatin-Rouge N, Stoll S, Buffle J. Size and pH effect on electrical and conformational behavior of poly(acrylic acid): simulation and experiment. Eur. Polym. J. 42(5), 1135-1144 (2006).
45. Staples CA, Murphy SR, Mclaughlin JE, Leung HW, Cascieri TC, Farr CH. Determination of selected fate and aquatic toxicity characteristics of acrylic acid and a series of acrylic esters. Chemosphere 40(1), 29-38 (2000).
46. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers. Biomaterials 17(2), 93-102 (1996).
47. Maurus PB, Kaeding CC. Bioabsorbable implant material review. Oper. Techn. Sport Med. 12(3), 158-160 (2004).
48. Pasut G, Veronese FM. State of the art in PEGylation: the great versatility achieved after forty years of research. J. Control. Release 161(2), 461-472 (2012).
49. Perry JL, Reuter KG, Kai MP et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 12(10), 5304-5310 (2012).
50. Kim K, Bae B, Kang YJ, Nam JM, Kang S, Ryu JH. Natural polypeptide-based supramolecular nanogels for stable noncovalent encapsulation. Biomacromolecules 14(10), 3515-3522 (2013).
51. Xing T, Mao CQ, Lai B, Yan LF. Synthesis of disulfidecrosslinked polypeptide nanogel conjugated with a nearinfrared fluorescence probe for direct imaging of reductioninduced drug release. ACS Appl. Mater. Inter. 4(10), 5662-5672 (2012).
52. Ferreira SA, Gama FM, Vilanova M. Polymeric nanogels as vaccine delivery systems. Nanomed. Nanotechnol. 9(2), 159-173 (2013).
53. Kimoto T, Shibuya T, Shiobara S. Safety studies of a novel starch, pullulan: chronic toxicity in rats and bacterial mutagenicity. Food Chem. Toxicol. 35(3-4), 323-329 (1997).
54. Kageyama S, Kitano S, Hirayama M et al. Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Sci. 99(3), 601-607 (2008).
55. Sunamoto J, Iwamoto K, Takada M, Yuzuriha T, Katayama K. Improved Drug Delivery to Target Specific Organs Using Liposomes as Coated with Polysaccharides. In: Polymers in Medicine. Chiellini E, Giusti P (Eds). Springer, NY, USA, 157-168 (1983).
56. Sunamoto J, Sato T, Hirota M, Fukushima K, Hiratani K, Hara K. A newly developed immunoliposome -an egg phosphatidylcholine liposome coated with pullulan bearing both a cholesterol moiety and an IgMs fragment. Biochim. Biophys. Acta 898(3), 323-330 (1987).
57. Akiyoshi K, Yamaguchi S, Sunamoto J. Self-aggregates of hydrophobic polysaccharide derivatives. Chem Lett. 20(7), 1263-1266 (1991).
58. Akiyoshi K, Sasaki Y, Sunamoto J. Molecular chaperonelike activity of hydrogel nanoparticles of hydrophobized pullulan: thermal stabilization with refolding of carbonic anhydrase B. Bioconjug. Chem. 10(3), 321-324 (1999).
59. Akiyoshi K, Kobayashi S, Shichibe S et al. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Control. Release 54(3), 313-320 (1998).
60. Nishikawa T, Akiyoshi K, Sunamoto J. Supramolecular assembly between nanoparticles of hydrophobized polysaccharide and soluble-protein complexation between the self-aggregate of cholesterol-bearing pullulan and alpha-chymotrypsin. Macromolecules 27(26), 7654-7659 (1994).
61. Ferreira SA, Coutinho PJG, Gama FM. Synthesis and characterization of self-assembled nanogels made of pullulan. Materials 4(4), 601-620 (2011).
62. Kumar D, Saini N, Pandit V, Ali S. An insight to pullulan: a biopolymer in pharmaceutical approaches. Int. J. Basic App. Sci. 1(3) 202-219 (2012).
63. Yang W-Z, Zhang Q-Q, Chen H-L et al. Preparation and physicochemical characteristics of self-assembled nanoparticles of cholesterol succinate modified pullulan conjugates. In: 7th Asian-Pacific Conference on Medical and Biological Engineering. Peng Y, Weng X (Eds). Springer, Berlin Heidelberg, Germany, 13-17 (2008).
64. Polysaccharide produced by aureobasidium pullulans ferm p4257 ii toxicity test and antitumor effect (1986). http://eurekamag.com/research/032/864/ polysaccharideproduced-aureobasidium-pullulans-ferm-p4257-ii-toxicitytest- antitumor-influence.php
65. Trautwein C, Boker K, Manns MP. Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms. Gut 35(9), 1163-1166 (1994).
66. Shiku H, Wang L, Ikuta Y et al. Development of a cancer vaccine: peptides, proteins, and DNA. Cancer Chemother. Pharmacol. 46(Suppl.), S77-S82 (2000).
67. Ferreira SA, Pereira P, Sampaio P, Coutinho PJG, Gama FM. Supramolecular assembled nanogel made of mannan. J. Colloid Interf. Sci. 361(1), 97-108 (2011).
68. Akiyoshi K, Deguchi S, Moriguchi N, Yamaguchi S, Sunamoto J. Self-aggregates of hydrophobized polysaccharides in water -formation and characteristics of nanoparticles. Macromolecules 26(12), 3062-3068 (1993).
69. Lee KY, Jo WH, Kwon IC, Kim YH, Jeong SY. Structural determination and interior polarity of self-aggregates prepared from deoxycholic acid-modified chitosan in water. Macromolecules 31(2), 378-383 (1998).
70. Lee KY, Jo WH, Kwon IC, Kim YH, Jeong SY. Physicochemical characteristics of self-aggregates of hydrophobically modified chitosans. Langmuir 14(9), 2329-2332 (1998).
71. Baik HJ, Oh NM, Oh YT et al. 3-Diethylaminopropylbearing glycol chitosan as a protein drug carrier. Colloids Surf. B Biointerf. 84(2), 585-590 (2011).
72. Lee J, Lee C, Kim TH et al. Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system. J. Control. Release 161(3), 728-734 (2012).
73. Nakai T, Hirakura T, Sakurai Y, Shimoboji T, Ishigai M, Akiyoshi K. Injectable hydrogel for sustained protein release by salt-induced association of hyaluronic acid nanogel. Macromol. Biosci. 12(4), 475-483 (2012).
74. Takahashi H, Sawada S, Akiyoshi K. Amphiphilic polysaccharide nanoballs: a new building block for nanogel biomedical engineering and artificial chaperones. ACS Nano. 5(1), 337-345 (2011).
75. Chen W, Zheng M, Meng F et al. In situ forming reductionsensitive degradable nanogels for facile loading and triggered intracellular release of proteins. Biomacromolecules 14(4), 1214-1222 (2013).
76. Rosenbaugh EG, Roat JW, Gao L et al. The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials 31(19), 5218-5226 (2010).
77. Jung YS, Park W, Na K. Temperature-modulated noncovalent interaction controllable complex for the longterm delivery of etanercept to treat rheumatoid arthritis. J. Control. Release 171(2), 143-151 (2013).
78. Choi JH, Jang JY, Joung YK, Kwon MH, Park KD. Intracellular delivery and anti-cancer effect of self-assembled heparin-Pluronic nanogels with RNase A. J. Control. 147(3), 420-427 (2010).
79. Nguyen DH, Joung YK, Choi JH, Moon HT, Park KD. Targeting ligand-functionalized and redox-sensitive heparin-Pluronic nanogels for intracellular protein delivery. Biomed. Mater. 6(5), (2011).
80. Ozawa Y, Sawada S, Morimoto N, Akiyoshi K. Selfassembled nanogel of hydrophobized dendritic dextrin for protein delivery. Macromol. Biosci. 9(7), 694-701 (2009).
81. Lim YT, Shim SM, Noh YW et al. Bioderived polyelectrolyte nanogels for robust antigen loading and vaccine adjuvant effects. Small 7(23), 3281-3286 (2011).
82. Li P, Luo ZC, Liu P et al. Bioreducible alginatepoly( ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses. J. Control. Release 168(3), 271-279 (2013).
83. Rejinold NS, Chennazhi KP, Tamura H, Nair SV, Jayakumar R. Multifunctional chitin nanogels for simultaneous drug delivery, bioimaging, and biosensing. ACS Appl. Mater. Inter. 3(9), 3654-3665 (2011).
84. Thomann-Harwood LJ, Kaeuper P, Rossi N, Milona P, Herrmann B, Mccullough KC. Nanogel vaccines targeting dendritic cells: Contributions of the surface decoration and vaccine cargo on cell targeting and activation. J. Control. Release 166(2), 95-105 (2013).
85. Dionisio M, Cordeiro C, Remunan-Lopez C, Seijo B, Da Costa AMR, Grenha A. Pullulan-based nanoparticles as carriers for transmucosal protein delivery. Eur. J. Pharm. Sci. 50(1), 102-113 (2013).
86. Rampino A, Borgogna M, Blasi P, Bellich B, Cesaro A. Chitosan nanoparticles: Preparation, size evolution and stability. Int. J. Pharm. 455(1-2), 219-228 (2013).
87. Steinhilber D, Witting M, Zhang XJ et al. Surfactant free preparation of biodegradable dendritic polyglycerol nanogels by inverse nanoprecipitation for encapsulation and release of pharmaceutical biomacromolecules. J. Control. Release 169(3), 289-295 (2013).
88. Chen Y, Zheng X, Qian H, Mao Z, Ding D, Jiang X. Hollow core-porous shell structure poly(acrylic acid) nanogels with a superhigh capacity of drug loading. ACS Appl. Mater. Interfaces 2(12), 3532-3538 (2010).
89. Bartlett RL, 2nd, Sharma S, Panitch A. Cell-penetrating peptides released from thermosensitive nanoparticles suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants. Nanomedicine 9(3), 419-427 (2013).
90. Smith MH, Lyon LA. Tunable Encapsulation of Proteins within Charged Microgels. Macromolecules 44(20), 8154-8160 (2011).
91. Huang YJ, Liu MZ, Gao CM et al. Ultra-small and innocuous cationic starch nanospheres: Preparation, characterization and drug delivery study. Int. J. Biol. Macromol. 58, 231-239 (2013).
92. Qiu LY, Bae YH. Polymer architecture and drug delivery. Pharmaceut. Res. 23(1), 1-30 (2006).
93. Nishikawa T, Akiyoshi K, Sunamoto J. Macromolecular complexation between bovine serum albumin and the self-assembled hydrogel nanoparticle of hydrophobized polysaccharides. J. Am. Chem. Soc. 118(26), 6110-6115 (1996).
94. Liu ZX, Lu DN, Yin L et al. Strengthening the stability of a tunnel-shaped homotetramer protein with Nanogels. J. Phys. Chem. B 115(28), 8875-8882 (2011).
95. Carvalho V, Castanheira P, Faria TQ et al. Biological activity of heterologous murine interleukin-10 and preliminary studies on the use of a dextrin nanogel as a delivery system. Int. J. Pharm. 400(1-2), 234-242 (2010).
96. Gonzalez-Toro DC, Ryu JH, Chacko RT, Zhuang JM, Thayumanavan S. Concurrent binding and delivery of proteins and lipophilic small molecules using polymeric nanogels. J. Am. Chem. Soc. 134(16), 6964-6967 (2012).
97. Zhao MX, Biswas A, Hu BL et al. Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials 32(22), 5223-5230 (2011).
98. Choi WI, Lee JH, Kim JY, Kim JC, Kim YH, Tae G. Efficient skin permeation of soluble proteins via flexible and functional nano-carrier. J. Control. Release 157(2), 272-278 (2012).
99. Kabanov AV, Vinogradov SV. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew. Chem. 48(30), 5418-5429 (2009).
100. Lee BR, Oh KT, Baik HJ, Youn YS, Lee ES. A chargeswitched nano-sized polymeric carrier for protein delivery. Int. J. Pharm. 392(1-2), 78-82 (2010).
101. Jin HQ, Tan H, Zhao LL et al. Ultrasound-triggered thrombolysis using urokinase-loaded nanogels. Int. J. Pharm. 434(1-2), 384-390 (2012).
102. Singh S, Topuz F, Hahn K, Albrecht K, Groll J. Embedding of active proteins and living cells in redoxsensitive hydrogels and nanogels through enzymatic crosslinking. Angew. Chem. Int. Ed. 52(10), 3000-3003 (2013).
103. Nagahama K, Ouchi T, Ohya Y. Biodegradable nanogels prepared by self-assembly of poly(l-lactide)-grafted dextran: entrapment and release of proteins. Macromol. Biosci. 8(11), 1044-1052 (2008).
104. Sunamoto J, Ushio K, Hidaka M: US 20070042970 A1 (2007).
105. Akiyoshi K, Kiyono H, Yuki Y, Nochi T: US 20110206729 A1 (2011).
106. Xia LW, Xie R, Ju XJ, Wang W, Chen QM, Chu LY. Nanostructured smart hydrogels with rapid response and high elasticity. Nat. Commun. 4, 2226 (2013).
107. Yu SY, Hu JH, Pan XY, Yao P, Jiang M. Stable and pHsensitive nanogels prepared by self-assembly of chitosan and ovalbumin. Langmuir 22(6), 2754-2759 (2006).
108. Tata BVR, Brijitta J, Joshi RG. Thermo-responsive nanogel dispersions: dynamics and phase behaviour. Int. J. Adv. Eng. Sci. Appl. Math. 5(4), 240-249 (2013).
109. Lowman AM, Morishita M, Kajita M, Nagai T, Peppas NA. Oral delivery of insulin using pH-responsive complexation gels. J. Pharm. Sci. 88(9), 933-937 (1999).
110. Uesugi Y, Kawata H, Jo J, Saito Y, Tabata Y. An ultrasoundresponsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy. J. Control. Release 147(2), 269-277 (2010).
111. Sasaki Y, Akiyoshi K. Development of an artificial chaperone system based on cyclodextrin. Curr. Pharm. Biotechnol. 11(3), 300-305 (2010).
112. Pan G, Guo Q, Cao C, Yang H, Li B. Thermo-responsive molecularly imprinted nanogels for specific recognition and controlled release of proteins. Soft Matter 9(14), 3840-3850 (2013).
113. Hayashi H, Iijima M, Kataoka K, Nagasaki Y. pH-Sensitive Nanogel Possessing Reactive PEG Tethered Chains on the Surface. Macromolecules 37(14), 5389-5396 (2004).
114. Majorek KA, Porebski PJ, Dayal A et al. Structural and immunologic characterization of bovine, horse, and rabbit serum albumins. Mol. Immunol. 52(3-4), 174-182 (2012).
115. Lin MM, Lu DN, Zhu JY, Yang C, Zhang YF, Liu Z. Magnetic enzyme nanogel (MENG): a universal synthetic route for biocatalysts. Chem. Commun. 48(27), 3315-3317 (2012).
116. Zhao MX, Hu BL, Gu Z, Joo KI, Wang P, Tang Y. Degradable polymeric nanocapsule for efficient intracellular delivery of a high molecular weight tumor-selective protein complex. Nano. Today 8(1), 11-20 (2013).
117. Li S, Meng F, Wang Z et al. Biodegradable polymersomes with an ionizable membrane: facile preparation, superior protein loading, and endosomal pH-responsive protein release. Eur. J. Pharm. Biopharm. 82(1), 103-111 (2012).
118. Shima F, Akagi T, Uto T, Akashi M. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(gamma-glutamic acid) nanoparticles. Biomaterials 34(37), 9709-9716 (2013).
119. Shen JM, Xu L, Lu Y et al. Chitosan-based luminescent/magnetic hybrid nanogels for insulin delivery, cell imaging, and antidiabetic research of dietary supplements. Int. J. Pharm. 427(2), 400-409 (2012).
120. Carvalho J, Gonalves C, Gil AM, Gama FM. Production and characterization of a new dextrin based hydrogel. Eur. Polym. J. 43(7), 3050-3059 (2007).
121. Carvalho V, Castanheira P, Madureira P et al. Selfassembled dextrin nanogel as protein carrier: controlled release and biological activity of IL-10. Biotechnol. Bioeng. 108(8), 1977-1986 (2011).
122. Hasegawa U, Sawada S, Shimizu T et al. Raspberry-like assembly of cross-linked nanogels for protein delivery. J. Control. Release 140(3), 312-317 (2009).